Heraeus’ Victory before the International Trade Commission

Arnold & Porter Kaye Scholer advised Heraeus on the deal.

Heraeus GmbH obtained a significant trade secret litigation victory at the International Trade Commission (ITC) over alleged business trade secrets relating to the sale of orthopedic bone cement. The Commission issued an opinion on June 23, 2021, affirming and adopting the Administrative Law Judge’s earlier February 11, 2021 decision after the ITC’s first full virtual trial conducted remotely via video because of restrictions due to the COVID-19 pandemic.

The Commission determined that Heraeus did not misappropriate trade secrets or engage in any tortious interference or false advertising, and further determined not to review the presiding Administrative Law Judge’s finding of no injury to a domestic injury.  

Heraeus is represented in the ITC and related US district court litigation by Arnold & Porter, led by partners John Nilsson (Picture) , David Caine, Philip Marsh, and Matt Wolf.

Involved fees earner: David Caine – Arnold & Porter Kaye Scholer LLP; Philip Marsh – Arnold & Porter Kaye Scholer LLP; John Nilsson – Arnold & Porter Kaye Scholer LLP; Matthew Wolf – Arnold & Porter Kaye Scholer LLP;

Law Firms: Arnold & Porter Kaye Scholer LLP;

Clients: Heraeus Medical, LLC;

Author: Martina Bellini